262-OR: Pemvidutide, a GLP-1/glucagon dual receptor agonist, in subjects with overweight or obesitya 48-week, placebo-controlled, phase 2 (MOMENTUM) trial
Coverage depends on your insurance, and again, coverage is very unlikely for weight loss: Private insurance usually covers Januvia, but only for type 2 diabetes, not weight loss
Bodybuilders and athletes, in particular, use this mechanism for faster and more efficient progress
Consider whether a specialist referral to an obesity medicine physician or endocrinologist would be appropriate
This typically involves a detailed health assessment, a review of your lab results, and a virtual consultation to determine if you are a candidate for a personalized weight loss program